Cargando…
Network Pharmacology Integrated Molecular Docking Reveals the Antiosteosarcoma Mechanism of Biochanin A
BACKGROUND: As the malignant tumor with the highest incidence in teenagers, osteosarcoma has become a major problem in oncology research. In addition to surgical management, the pharmacotherapeutic strategy for osteosarcoma treatment is an attractive way to explore. It has been demonstrated that bio...
Autores principales: | Luo, Qing, Shi, Xuan, Ding, Jiarong, Ma, Zhenzhen, Chen, Xumei, Leng, Yuanxiu, Zhang, Xuhui, Liu, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339762/ https://www.ncbi.nlm.nih.gov/pubmed/30723510 http://dx.doi.org/10.1155/2019/1410495 |
Ejemplares similares
-
Microbial Glycosylation of Daidzein, Genistein and Biochanin A: Two New Glucosides of Biochanin A
por: Sordon, Sandra, et al.
Publicado: (2017) -
Bioinformatics and in-silico findings reveal medical features and pharmacological targets of biochanin A against colorectal cancer and COVID-19
por: Qin, Jingru, et al.
Publicado: (2021) -
Clinicopathological and prognostic significance of zinc finger antisense 1 overexpression in cancers: A meta-analysis
por: Leng, Yuanxiu, et al.
Publicado: (2018) -
Integration of molecular docking, molecular dynamics and network pharmacology to explore the multi‐target pharmacology of fenugreek against diabetes
por: Luo, Wenfeng, et al.
Publicado: (2023) -
EFFECT OF BIOCHANIN – A AGAINST FILARIAL VECTOR
por: Nagarajan, N.S., et al.
Publicado: (1998)